MU Stage 2 provides insight into state cancer registry issues and initiates ambulatory physician reporting and interoperability for cancer cases through one of the public health EP Menu set objectives. State cancer registry reporting in MU Stage 2 includes additional clinical data from physicians in addition to existing lab data provided by hospitals enhancing the scope and range of cancer data sources. Key outpatient and ambulatory specialty areas for electronic cancer reporting include dermatology, urology, gastroenterology, hematology, medical oncology, radiation oncology, and ambulatory surgery centers.
The table below provides the state cancer registry objective and measure.
| Public Health State Cancer Registry Objective - EP | |
|---|---|
| Stage 1 | Stage 2 – Menu set |
| Was not an objective in Stage 1 | Capability to identify and report cancer cases to a public health central cancer registry, except where prohibited, and in accordance with applicable law and practice |
| Public Health State Cancer Registry Measure - EP | |
|---|---|
| Stage 1 | Stage 2 |
| None | Successful ongoing submission of cancer case information from a certified electronic health record technology (CEHRT) to a public health central cancer registry for the entire EHR reporting period |